Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients

NCT03139630 is registered in ClinicalTrials.gov with Franck Boccara as lead sponsor.

NCT NCT03139630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03139630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients
Lead sponsor
Franck Boccara
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
September 30, 2016
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, hiv seropositivity, pcsk9